ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,722.26
      -0.19%
      US Tech 100
      19,517.20
      0.53%
      Dow Jones
      41,914.75
      -0.70%
      Brent Oil
      73.035
      -0.21%
      Bitcoin
      63,237.63
      0.17%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Athersys Inc (ATHX) Quote

      Athersys Inc

      Athersys Inc (ATHX)

      NASDAQ
      0.1018
      0.00
      (0.00%)
      At close: September 25 4:00PM
      Delayed by 15 minutes
      0.1018
      0.00
      ( 0.00% )
      After Hours: -
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.1018
      Bid
      0.101
      Ask
      0.104
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      1.831M
      Previous Close
      0.1018
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      17,986,000
      Dividend Yield
      -
      PE Ratio
      0.00
      Earnings Per Share (EPS)
      -4.03
      Revenue
      5.33M
      Net Profit
      -72.53M

      About Athersys Inc

      Athersys Inc is a biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is an unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are foc... Athersys Inc is a biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is an unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.athersys.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -

      Ask ADVFN Intelligence (AI)

      ATHX Latest News

      More News

      Form 8-K - Current report

      January 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      December 22 2023
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 21 2023
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 16 2023
      Edgar (US Regulatory)

      Form 8-K - Current report

      October 18 2023
      Edgar (US Regulatory)

      Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives

      Athersys, Inc. (Nasdaq: ATHX), (“Athersys” or the “Company”) a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announces it has...

      October 16 2023
      Business Wire

      Form 8-K - Current report

      October 12 2023
      Edgar (US Regulatory)

      Form 8-K - Current report

      October 11 2023
      Edgar (US Regulatory)

      Athersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with Healios

      The MOU includes $1.5M to $4.5M near term payments plus up to $150M in milestones Athersys, Inc. (Nasdaq: ATHX), a cell therapy and regenerative medicine company developing MultiStem®...

      October 10 2023
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      October 06 2023
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      RZLVRezolve AI Ltd
      $ 7.44
      (51.22%)
      		3.17M
      RNAZTransCode Therapeutics Inc
      $ 0.63
      (51.12%)
      		12.71M
      ATGLAlpha Technology Group Limited
      $ 2.16
      (49.72%)
      		3.41M
      INVZWInnoviz Technologies Ltd
      $ 0.18
      (45.69%)
      		11.02k
      OCTOEightco Holdings Inc
      $ 3.61
      (44.98%)
      		100.58M
      VTNRVertex Energy Inc
      $ 0.1501
      (-58.42%)
      		49.64M
      CMCTCreative Media and Community Trust Corporation
      $ 0.71
      (-54.63%)
      		3.56M
      SFIXStitch Fix Inc
      $ 2.28
      (-39.20%)
      		23.87M
      SHOTWSafety Shot Inc
      $ 0.22
      (-31.25%)
      		11.82k
      ARQQArqit Quantum Inc
      $ 4.40
      (-29.63%)
      		438.5k
      NVDANVIDIA Corporation
      $ 123.51
      (2.18%)
      		284.21M
      MLGOMicroAlgo Inc
      $ 0.2744
      (26.92%)
      		142.15M
      CEROCERo Therapeutics Holdings Inc
      $ 0.0986
      (5.23%)
      		123.48M
      SQQQProShares UltraPro Short QQQ
      $ 7.47
      (-2.35%)
      		123.42M
      INTCIntel Corporation
      $ 23.54
      (3.20%)
      		116.89M

      Discussion

      View Full Feed
      TooFrank TooFrank 4 minutes ago
      LEI BRAVADA INTERNATIONAL, LTD

      2023-08-04
      LEI Issuer Old Value I Amsterdam Netherlands EVK05KS7XY1DEII3R011
      LEI Issuer New Value is Bloomberg 5493001KJTIIGC8Y1R12 Status: Lapsed

      Bloomberg can become the Legal Entity Identifier (LEI) for a company when th
      BRAV
      biosectinvestor biosectinvestor 4 minutes ago
      Thanks LTR. Yeah, I think the fact that these people feel the need to constantly comment and are either shorts or being paid by someone, suggests that some interest thinks that if they do not constantly invest an immense amount of effort and time, the company and stock will do way better and that wi
      NWBO
      georgejjl georgejjl 4 minutes ago
      Tesla Q3 deliveries expected to rise 8% YOY

      https://www.teslarati.com/tesla-q3-2024-deliveries-forecast-barclays/

      Good luck and GOD bless,
      TSLA
      peafunke peafunke 4 minutes ago
      I’m usually able to no problem.
      TPTW
      titan11 titan11 5 minutes ago
      Last time you made that statement you wound up with balls on your chin! Lol
      IGPK
      jsw10011 jsw10011 5 minutes ago
      You have too much time on your hands I guess since you don’t hold this ticker.
      IBGR
      1vman 1vman 5 minutes ago
      ***** 🅰️🅰️🅰️ DBMM has had 1 name change , 3 ticker symbol changes and 2 R/S

      SOURCE
      https://www.otcmarkets.com/stock/DBMM/security

      ENOUGH SAID
      DBMM
      Pittsburgh Boy Pittsburgh Boy 6 minutes ago
      The audit isn't finalized yet
      TXTM
      tw0122 tw0122 6 minutes ago
      MU and SOXL pump tomorrow so after that looking good for UVIX loading as $VIX $14.72- $15.43 is a good zone to load up UVIX
      $SVIX closed out at $15.41

      as the masters want to tell you there is no volatility in these markets …all is well..lol
      SOXL SVIX UVIX
      ANTI-BAGHOLDER ANTI-BAGHOLDER 6 minutes ago
      Hater? You mean truth teller? I have already traded this a couple times.

      I don’t baghold.
      SINC
      1vman 1vman 7 minutes ago
      *****🅰️🅰️🅰️ These spin offs rarely amount to anything in the way of shareholder value

      ENOUGH SAID
      HCWC
      Looking4BIGcash Looking4BIGcash 7 minutes ago
      Thank you for the invite to your beautiful city. It is on my list for 2025. I travel to Europe and the UK often and have been intrigued by Spain but somehow keep getting pulled to Portugal by friends (and an Ex) ;) I will be heading to Ibiza (finally) next Summer and I do have friends in Barcelona I
      WDDD
      Wrangler1 Wrangler1 7 minutes ago
      “Extended Quiet Period”. Translation. They have nothing to report. It’s been SEVEN months since Ken said that two liquidity events were on target to close by the end of Q1. This is the same BS Ken pulled TWO years ago in Q4 2022. He did go out and get another job so he is probably busy with actually
      WDLF
      littlejohn littlejohn 8 minutes ago
      Oil dropped?, helene will boost fuel demand

      after landfall for a lot of cleanup...

      diesel demand will get boosted...

      inventory report on Wednesday was

      bullish with lower inventory...

      some gulf of Mexico production is
      valuemind valuemind 8 minutes ago
      AYSI: thanks for your update!
      jour_trader jour_trader 8 minutes ago
      I believe there are 2 cases against Accord. This is one of them.
      ELTP
      Backstabbed Backstabbed 10 minutes ago
      S1 cancellation soon? I don’t see an approved filing yet!
      DBGI
      titan11 titan11 11 minutes ago
      Just some Boston beans creatin some hot air!
      ASII
      Art67 Art67 11 minutes ago
      dead people live in past.
      WDLF
      1vman 1vman 11 minutes ago
      *****🅰️🅰️🅰️ WOW !!! 50 billion share authorized here

      PEE YEW stinky OTC pinky here

      https://www.otcmarkets.com/stock/UBQU/security

      ENOUGH SAID
      UBQU
      SSKILLZ1 SSKILLZ1 12 minutes ago
      VLN.TO Was the best performing stock pick today picked by MAXLUKE1. and the Best Top Pick was INTC picked by DEADJIM. hope this helps.
      INTC

      Your Recent History

      NASDAQ
      ATHX
      Athersys
      Delayed Upgrade Clock